Wockhardt on Monday announced that the company's board will meet on Thursday, 6 January 2022 to consider and approve various fund-raising options.
The drug maker further said that details of the proposal shall be intimated in the outcome of the meeting.Wockhardt is a research based global pharmaceutical and biotech company. The company reported a consolidated net profit of Rs 34 crore in Q2 FY22 as against a net profit of Rs 4 crore in Q2 FY21. Sales increased by 21% YoY to Rs 862 crore during the quarter.
Shares of Wockhardt were trading 2.13% higher at Rs 421.20 on BSE.
Powered by Capital Market - Live News